Game-changing news: Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with ...

Dec 12 (Reuters) - Novo Nordisk said on Friday the European Medicines Agency's committee had issued a positive opinion for a ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

Researchers say new compound improves metabolic activity within muscles instead of acting on hunger pathways like Ozempic and ...

Ozempic and Wegovy, have lately, become popular weight-loss drugs. Recent research shows how these drugs can work on the brain to control hunger, cravings, and thirst. The findings could help people ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

NEW YORK, Dec 10 (Reuters) - Online telehealth company Hims and Hers Health is launching its weight-loss membership and ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...